How C(D)MOs embark on pharma digital transformation

CDMOs and CMOs (contract development/manufacturing organizations) in today's pharmaceutical markets are facing major challenges. Digitalization of key manufacturing and supply chain processes can help them to become more agile, responsive and resilient in meeting customer demands while managing complex regulatory requirements and avoid supply chain disruptions. Our white paper offers insights and strategies to help CDMOs and CMOs remain competitive in an evolving market, while delivering cost-efficient and effective services to their customers. 

Key challenges like increasingly diverse customer demands, vulnerable supply chains, evolving regulatory requirements and efficient, flexible and swift operations are forcing CDMOs and CMOs to start their digitalization journey and set up roadmaps to reach Pharma 4.0. The pressure to adopt digital technologies is growing and pharma digital transformation is challenging, but it is the only solution if CDMOs and CMOs want to become “future ready”. 

One of the most important steps in digitizing pharma processes is implementing a Manufacturing Execution System (MES) like Werum PAS-X MES by Körber. By helping pharma manufacturers create flawless manufacturing processes and plan their production efficiently and flexibly, MES reduce risk, time, costs and effort and increase process efficiency, product quality, and business agility.